These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36792635)

  • 1. Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula.
    Suzuki T; Morioka S; Yamamoto K; Saito S; Iida S; Teruya K; Takasaki J; Hojo M; Hayakawa K; Kutsuna S; Miyamoto S; Ozono S; Suzuki T; Kodama EN; Ohmagari N
    Sci Rep; 2023 Feb; 13(1):2669. PubMed ID: 36792635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of SARS-CoV-2 Aerosols Dispersed During Noninvasive Respiratory Support of Patients With COVID-19.
    Ramsey ME; Faugno AJ; Puryear WB; Lee BC; Foss AD; Lambert LH; Nargi FE; Bopp GP; Lee LP; Rudzinski CM; Ervin BL; Runstadler JA; Hill NS
    Respir Care; 2023 Jan; 68(1):8-17. PubMed ID: 36566031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High flow nasal cannula in COVID-19: a literature review.
    Gürün Kaya A; Öz M; Erol S; Çiftçi F; Çiledağ A; Kaya A
    Tuberk Toraks; 2020 Jul; 68(2):168-174. PubMed ID: 32755117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-flow nasal cannula for acute hypoxemic respiratory failure in patients with COVID-19: systematic reviews of effectiveness and its risks of aerosolization, dispersion, and infection transmission.
    Agarwal A; Basmaji J; Muttalib F; Granton D; Chaudhuri D; Chetan D; Hu M; Fernando SM; Honarmand K; Bakaa L; Brar S; Rochwerg B; Adhikari NK; Lamontagne F; Murthy S; Hui DSC; Gomersall C; Mubareka S; Diaz JV; Burns KEA; Couban R; Ibrahim Q; Guyatt GH; Vandvik PO
    Can J Anaesth; 2020 Sep; 67(9):1217-1248. PubMed ID: 32542464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Aerosol Formation During High-Flow Nasal Cannula Treatment in Critically Ill Subjects.
    Bem RA; van Mourik N; Klein-Blommert R; Spijkerman IJ; Kooij S; Bonn D; Vlaar AP
    Respir Care; 2021 Jun; 66(6):891-896. PubMed ID: 33536316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rationale for Use of High Flow Nasal Cannula for Select Patients With Suspected or Confirmed Severe Acute Respiratory Syndrome Coronavirus-2 Infection.
    Suffredini DA; Allison MG
    J Intensive Care Med; 2021 Jan; 36(1):9-17. PubMed ID: 32912049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians.
    Koyauchi T; Suzuki Y; Inoue Y; Hozumi H; Karayama M; Furuhashi K; Fujisawa T; Enomoto N; Inui N; Suda T
    Respir Investig; 2022 Nov; 60(6):779-786. PubMed ID: 36153288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High flow nasal cannula for adult acute hypoxemic respiratory failure in the ED setting.
    Long B; Liang SY; Lentz S
    Am J Emerg Med; 2021 Nov; 49():352-359. PubMed ID: 34246166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.
    Hultström M; Hellkvist O; Covaciu L; Fredén F; Frithiof R; Lipcsey M; Perchiazzi G; Pellegrini M
    Crit Care; 2022 Mar; 26(1):55. PubMed ID: 35255949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Flow Nasal Cannula Therapy in Patients With COVID-19: Predictive Response Factors.
    Raboni SM; Neves VC; Silva RM; Breda GL; Ceregato AC; Broza TP; de Oliveira G; Melo-Diaz LL; Braga CB; Carraro CF; Arroyo NC; Bardy RF; Devetak GF; Ozawa CM; Graf ME; Dias VL; Ducroquet MA; Nunes DP; Sokoloski CS; Petterle RR
    Respir Care; 2022 Nov; 67(11):1443-1451. PubMed ID: 35944966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-flow nasal cannula oxygen therapy in hypoxic patients with COVID-19 pneumonia: A retrospective cohort study confirming the utility of respiratory rate index.
    Takeshita Y; Terada J; Hirasawa Y; Kinoshita T; Tajima H; Koshikawa K; Kinouchi T; Isaka Y; Shionoya Y; Tada Y; Tsushima K
    Respir Investig; 2022 Jan; 60(1):146-153. PubMed ID: 34772644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes.
    Costa WNDS; Miguel JP; Prado FDS; Lula LHSM; Amarante GAJ; Righetti RF; Yamaguti WP
    Respir Physiol Neurobiol; 2022 Apr; 298():103842. PubMed ID: 35026479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxygen debt as a predictor of high-flow nasal cannula therapy failure in SARS-CoV-2 patients with acute respiratory failure: A retrospective cohort study.
    Michel PG; Claudia PH; Andrea RS; Maria DA; Henry RA
    Heart Lung; 2024; 64():176-181. PubMed ID: 38278127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure.
    Raoof S; Nava S; Carpati C; Hill NS
    Chest; 2020 Nov; 158(5):1992-2002. PubMed ID: 32681847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of High-Flow Nasal Cannula and Noninvasive Ventilation in Acute Hypoxemic Respiratory Failure Due to Severe COVID-19 Pneumonia.
    Nair PR; Haritha D; Behera S; Kayina CA; Maitra S; Anand RK; Ray BR; Soneja M; Subramaniam R; Baidya DK
    Respir Care; 2021 Dec; 66(12):1824-1830. PubMed ID: 34584010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: A systematic review.
    Lee CC; Mankodi D; Shaharyar S; Ravindranathan S; Danckers M; Herscovici P; Moor M; Ferrer G
    Respir Med; 2016 Dec; 121():100-108. PubMed ID: 27888983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-flow nasal cannula
    He Y; Liu N; Zhuang X; Wang X; Ma W
    Ther Adv Respir Dis; 2022; 16():17534666221087847. PubMed ID: 35318888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
    Chandel A; Patolia S; Brown AW; Collins AC; Sahjwani D; Khangoora V; Cameron PC; Desai M; Kasarabada A; Kilcullen JK; Nathan SD; King CS
    Respir Care; 2021 Jun; 66(6):909-919. PubMed ID: 33328179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy on the clinical efficacy of coronavirus disease 2019 patients with acute respiratory distress syndrome].
    Zhao Z; Cao H; Cheng Q; Li N; Zhang S; Ge Q; Shen N; Yang L; Shi W; Bai J; Meng Q; Wu C; Wang B; Li Q; Yao G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):708-713. PubMed ID: 34296691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of surgical mask with high-flow nasal cannula (HFNC) leads to improved oxygenation in patients with COVID-19: a set of case reports].
    Smaha J; Kužma M; Brázdilová K; Jackuliak P; Payer J
    Vnitr Lek; 2021; 67(E-2):29-33. PubMed ID: 34074102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.